Shopping Cart
- Remove All
- Your shopping cart is currently empty
SGN-2FF is an oral fucosyltransferase inhibitor with antitumor activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $90 | In Stock | |
5 mg | $163 | In Stock | |
10 mg | $289 | In Stock | |
25 mg | $578 | In Stock | |
50 mg | $788 | In Stock | |
100 mg | $1,120 | In Stock | |
1 mL x 10 mM (in DMSO) | $198 | In Stock |
Description | SGN-2FF is an oral fucosylation inhibitor and inhibits fucosyltransferase activity, and has antitumor activity. |
In vitro | SGN-2FF is a fucosylation inhibitor, SGN-2FF inhibits cellular fucosylation by depleting the fucosylation substrate GDP-fucose, and by direct inhibition of fucosyltransferases, and leads to the production of fucosylated glycoproteins including antibodies. SGN-2FF activates human T cells in an antigen-dependent manner. |
In vivo | In multiple mouse tumor models, SGN-2FF exhibits antitumor activity. SGN-2FF shows substantial tumor growth delay. SGN-2FF elevates the protective effect of a lymphoma vaccine in a syngeneic mouse model. |
Molecular Weight | 166.15 |
Formula | C6H11FO4 |
Cas No. | 2089647-47-0 |
Smiles | C[C@@H]1OC(O)[C@@H](F)[C@H](O)[C@@H]1O |
Relative Density. | 1.42 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | H2O: 35 mg/mL (210.65 mM), Sonication is recommended. DMSO: 50 mg/mL (300.93 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
H2O/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.